针对髓增殖性瘤中的线粒体功能障碍:当前的策略和未来的方向 - - 一个叙述性综述
Nagham Al Dirani1, Fatima Soufan2, Kholoud Al Jebawi1,3
1Department of Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Annals of medicine and surgery (2012)
|November 3, 2025
概括
线粒体功能障碍驱动骨髓增殖性新生体 (MPNs) 血液癌症. 用基因编辑等新疗法准线粒体,通过解决代谢异常,为MPNs提供了有希望的治疗方法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 骨髓增殖性瘤 (MPNs) 是由激活JAK-STAT通路的遗传突变驱动的血液癌症.
- 线粒体功能障碍,包括ROS增加和动态变化,显著促进MPN的发展和进展.
- 这种功能障碍促进异常细胞增殖,并抑制MPN细胞的细胞亡.
研究的目的:
- 审查线粒体功能障碍在MPN病变发生中的作用.
- 突出针对MPNs中的线粒体通路的创新治疗策略.
- 强调MPN治疗的个性化医疗方法.
主要方法:
- 对MPNs和线粒体功能障碍的当前文献的综述.
- 针对线粒体的治疗策略的分析,包括抗氧化剂,代谢抑制剂和线粒体调节剂.
- 探索新兴技术,如基因编辑和基于RNA的疗法.
主要成果:
- 线粒体功能障碍是MPN克隆扩张和抗亡的关键驱动因素.
- 针对线粒体通路,例如通过抗氧化剂和代谢抑制剂,显示出治疗潜力.
- 基因编辑和RNA疗法等创新方法为治疗MPN提供了新的途径.
结论:
- 线粒体功能障碍是MPN的关键治疗标.
- 包括基因编辑,RNA疗法和个性化药物在内的新策略对于改善MPN治疗结果至关重要.
- 需要进一步的研究来完善这些疗法,并开发有效的组合治疗.
更多相关视频
03:57Assessment of Mitochondrial Oxygen Consumption Using a Plate Reader-based Fluorescent Assay
Published on: April 12, 2024
955
10:17Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
Published on: September 24, 2021
3.1K
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
